IVAX markets generic version of Alphagan

IVAX Corp. joins the growing number of drug manufacturers to market its version of brimonidine tartrate ophthalmic solution 0.2%.

Related Videos
Related Content

LaZrPlastique: The non–cutting edge over LASIK

March 22nd 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

The evolution of corneal transplantation surgery

March 21st 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

Study: New gene-editing technique reverses vision loss in mice

March 20th 2023

Moorfields Eye Hospital surgeon saves the vision —and the career— of future dentist

March 20th 2023

LaZrPlastique: The non–cutting edge over LASIK

March 22nd 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

The evolution of corneal transplantation surgery

March 21st 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

Study: New gene-editing technique reverses vision loss in mice

March 20th 2023

Moorfields Eye Hospital surgeon saves the vision —and the career— of future dentist

March 20th 2023

LaZrPlastique: The non–cutting edge over LASIK

March 22nd 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

The evolution of corneal transplantation surgery

March 21st 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

Study: New gene-editing technique reverses vision loss in mice

March 20th 2023

Moorfields Eye Hospital surgeon saves the vision —and the career— of future dentist

March 20th 2023
© 2023 MJH Life Sciences

All rights reserved.